Zydus Lifesciences receives Rs 1.61-cr GST demand for FY 2017-18

Image
Last Updated : Nov 29 2024 | 12:16 PM IST

Zydus Lifesciences has informed that it has received a demand order-in-original (O-I-O) of Rs 1.61 crore from the Assistant Commissioner, Division Dehradun, Sector-7, Uttarakhand, concerning the financial year 2017-18.

The issue pertains to the Input Tax Credit (ITC) carried forward through the TRAN-1 form.

The company has been asked to pay a tax demand and penalty totaling Rs 1.61 crore. This demand relates to the alleged ITC carried forward through the TRAN-1 during FY 2017-18. The company clarified that it has not received any prior notice or show cause notice regarding the demand.

The firm intends to challenge the order by filing an appeal. The company has stated that the demand will not have any material financial impact on its operations.

Zydus Lifesciences is a discovery-driven, global life sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.

The companys consolidated net profit increased 13.8% to Rs 911.20 crore in Q2 FY25 as against Rs 800.70 crore posted in Q2 FY24. Revenue from operations jumped 20.1% to Rs 5,113.60 crore in the quarter ended 30 September 2024.

The scrip rose 2% to Rs 967.35 on the BSE.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 29 2024 | 12:04 PM IST

Next Story